Thromboelastography-derived Functional Fibrinogen Levels

Completed

Conditions studied: Focus of Study, Coagulation Status of Cardiac Surgery Patient, Reducing Excess Blood Transfusion

In brief

This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirements

Key facts

Study ID

NCT01992757

Run by

University of Pennsylvania

People needed

51

Starts

2013-11-01

Expected to finish

2015-08-01

Last updated by the study team

2018-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Elective cardiac surgery patients who are undergoing primary cardiac surgery

You may not qualify if…

• Emergency surgery
• Re-operative cardiac surgery
• History of hypercoagulable state as defined in medical record
• Anticoagulated status at time of surgery
• Plasma requirement prior to discontinuation of bypass (alters fibrinogen level)

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.